May 7, 2026
In Part 2, Nanette K. Wenger examines how underrepresentation in research shaped cardiovascular epidemiology in women. Learn about the impact of key guideline developments, and where critical data gaps remain.
Timestamps:
1:09 – Historical underrepresentation
5:05 – Evidence gaps